Propionic acidemia (PA) is a severe metabolic disorder caused by mutations in the PCCA gene. Traditional treatments, including stringent life-long…
See where grants have been awarded across Minnesota.
Michael Barry, PhD
2024-2028
Our goal with this grant is to push innovation to increase yield and lower production cost for targeted proteins, using molecular farming. Reducing…
2022-2023
LEAH Labs is an innovative biotech startup headquartered at Mayo Clinic's 'Hatchery Lab' developing regenerative cell therapies, first focused on…
2022-2023
This project aims to develop and implant a preclinical model of a regenerative tissue tube for nerve repair. The TRUE™ Tissue allogeneic biomaterial…
2022-2023
1) Build and test a customer demonstration model of the liquid nitrogen-free cryogenic storage system. This system will allow storage and…
2022-2023
We are developing a one-time treatment for durable remission of HIV, after which patients will no longer need to take traditional antiretroviral…
2022-2023
Our ultimate goal is to bring our chondrocyte product, harvested from human induced pluripotent cell derived multi tissue organoids, into human…
2022-2024
To elucidate how muscle vascular regeneration is regulated during muscle remodeling.
To identify the interactions between muscle stem cells and…
2022-2024
The goal of this project is to describe a new field of science: peroxisome transfer. This has never been shown, and we are poised to be the first lab…
2022-2024
Type 2 diabetes is a highly prevalent chronic condition that affects Minnesotans' quality of life while also imparting a significant financial burden…
2022-2024
The goal of this project is to test the efficacy of intraspinal administration of the protein Netrin-1 (NTN1), as a therapeutical approach to promote…
2022-2024
The overall goal of this project is to develop a novel biological therapy to treat rotator cuff tears, which is a common injury that causes shoulder…
2022-2024